Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Assets:
Cash and due from banks	$ 681,325	$ 722,906
Interest-bearing deposits	8,183,080	9,495,777
Federal funds sold	0	5,925
Resell agreements	9,650	9,650
Total cash and cash equivalents	8,874,055	10,234,258
Securities held to maturity, net of allowance for credit losses of $500 at 2025 and $310 at 2024	3,431,179	3,533,775
Securities available for sale, at estimated fair value	15,970,596	15,043,625
Trading account securities	37,604	33,910
Loans, net of unearned discounts	21,891,812	20,754,813
Less: Allowance for credit losses on loans	(281,495)	(270,151)
Net loans	21,610,317	20,484,662
Premises and equipment, net	1,313,225	1,245,377
Accrued interest receivable and other assets	1,804,448	1,944,652
Total assets	53,041,424	52,520,259
Liabilities:
Non-interest-bearing demand deposits	14,143,815	14,441,820
Interest-bearing deposit	28,774,049	28,280,928
Total deposits	42,917,864	42,722,748
Federal funds purchased	18,775	21,975
Repurchase agreements	4,525,855	4,342,941
Junior subordinated deferrable interest debentures, net of unamortized issuance costs	123,242	123,184
Subordinated notes, net of unamortized issuance costs	99,804	99,648
Accrued interest payable and other liabilities	782,848	1,311,175
Total liabilities	48,468,388	48,621,671
Shareholders’ Equity:
Preferred stock, par value $0.01 per share; 10,000,000 shares authorized; 150,000 Series B shares ($1,000 liquidation preference) issued in 2025 and 2024	145,452	145,452
Common stock, par value $0.01 per share; 210,000,000 shares authorized; 64,404,582 shares issued in both 2025 and 2024	644	644
Additional paid-in capital	1,100,327	1,075,572
Retained earnings	4,309,171	3,951,482
Accumulated other comprehensive income (loss), net of tax	(842,951)	(1,252,004)
Treasury stock, at cost; 1,117,394 shares in 2025 and 207,150 in 2024	(139,607)	(22,558)
Total shareholders’ equity	4,573,036	3,898,588
Total liabilities and shareholders’ equity	$ 53,041,424	$ 52,520,259